Due to interest from our existing client base we have opened our Biotech fund before its planned IPO in Q4 2019. We bring more than 20 years of analyzing and trading biotech companies. We put
Please find our 2018 report below. We are looking forward to answer any questions or inquiries you might have. Please feel free to contact us.
Since the financial crisis in 2008 the global economy and financial markets have been on a diet of free steroids provided by central banks and politicians pushing the pedal via fiscal and monetary stimulus. The